Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BOL-DP-o-04
- Development stage
- Phase 2
- Lead developer
- BOL Pharma
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Administration
- Sublingual
01
Overview
BOL-DP-o-04 is a sublingual formulation of medical cannabis developed by Breath of Life (BOL) Pharma for the treatment of pain, including pain associated with diabetic neuropathy and chronic pain in patients undergoing hemodialysis. It is classified as an analgesic and cannabinoid. The drug acts as a **cannabinoid receptor modulator**, containing both trans-delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a 1:6 ratio. Clinical studies have shown that short-term use was generally well tolerated in patients with end-stage kidney disease on hemodialysis, with most adverse events being mild to moderate and resolving spontaneously[1][3][5]. The product is not considered a new molecular entity.
- Other names
- BOL-DP-o-04 + SCOBOL-DP-o-04 + SOC
02
Targets
HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))CNR1 (Cannabinoid receptor 1)TRPV1 (Transient receptor potential cation channel subfamily V member 1)
Beyond the preview
Go deeper on BOL-DP-o-04.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BOL-DP-o-04.